Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-032319
Filing Date
2024-10-28
Accepted
2024-10-28 17:18:29
Documents
1
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 (SERIES F) rdgdoc.html 4  
1 FORM 4 (SERIES F) rdgdoc.xml 4 3652
  Complete submission text file 0001437749-24-032319.txt   5219
Mailing Address C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
GERAGHTY JAMES A (Reporting) CIK: 0001239746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 241401898

Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)